Boston ScientificBSXEarnings & Financial Report
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
BSX Q4 2025 Key Financial Metrics
营收
$5.3B
毛利润
$3.7B
营业利润
$825.0M
净利润
$670.0M
毛利率
69.6%
营业利润率
15.6%
净利率
12.7%
同比增长
15.8%
EPS
$0.45
资金流向
Boston Scientific Q4 2025 Financial Summary
Boston Scientific reported revenue of $5.3B for Q4 2025, with a net profit of $670.0M (12.7% margin). Cost of goods sold was $1.6B, operating expenses totaled $2.9B.
Key Financial Metrics
| Total Revenue | $5.3B |
|---|---|
| Net Profit | $670.0M |
| Gross Margin | 69.6% |
| Operating Margin | 15.6% |
| Report Period | Q4 2025 |
Boston Scientific Annual Revenue by Year
Boston Scientific annual revenue history includes year-by-year totals (for example, 2025 revenue was $20.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $20.1B |
| 2024 | $16.7B |
| 2023 | $14.2B |
| 2022 | $12.7B |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $3.86B | $4.12B | $4.21B | $4.56B | $4.66B | $5.06B | $5.07B | $5.29B |
| 同比增长 | 13.8% | 14.5% | 19.3% | 22.5% | 20.9% | 22.8% | 20.3% | 15.8% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $36.67B | $37.11B | $38.08B | $39.40B | $40.14B | $41.56B | $42.71B | $43.67B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $19.93B | $20.37B | $20.71B | $21.77B | $22.21B | $22.42B | $23.39B | $24.23B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $164.0M | $813.0M | $1.00B | $1.46B | $541.0M | $1.29B | $1.34B | $1.36B |
Other Health Care Companies
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M
DXCM
Dexcom
营收
$1.3B
净利润
$267.3M
EW
Edwards Lifesciences
营收
$1.6B
净利润
$291.1M
GEHC
GE HealthCare
营收
$5.7B
净利润
$588.0M
HOLX
Hologic
营收
$1.0B
净利润
$179.1M
IDXX
Idexx Laboratories
营收
$1.1B
净利润
$274.6M
PODD
Insulet Corporation
营收
$783.7M
净利润
$101.6M
ISRG
Intuitive Surgical
营收
$2.9B
净利润
$794.8M